B. Bridji - Concepedia

Concepedia

Author

B. Bridji

Institut Génétique Nantes Atlantique

Also Known As

B Bridji, B. BRIDJI, B. Bridji, Boumediene Bridji, Boumédiene Bridji, Boumédiène Bridji, Bridji, B., Bridji, Boumediene, S. Zerdoud

51

Publications

1.8K

Citations

14

H-Index

29

Concepts

All Affiliations

Institut Génétique Nantes Atlantique Inserm Centre Eugène Marquis Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers Nantes Université

BB

About

B. Bridji is an author at Institut Génétique Nantes Atlantique specializing in medicine, radiology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	639
2	Health Sciences	8	8	587
3	Pathology	3	3	363
4	Engineering	1	1	12
5	Obstetrics	1	1	12

B. Bridji

×

16

Publications

1.8K

Citations

14

H-Index

	Year	Citations
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer Martin Schlumberger, Bogdan Catargi, Isabelle Borget, New England Journal of Medicine	2012	681
Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography Caroline Rousseau, Anne Devillers, Christine Sagan, Journal of Clinical Oncology	2006	310
Positron Emission Tomography With [<sup>18</sup>F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Study Max Lonneux, Marc Hamoir, H Reychler, Journal of Clinical Oncology Oncologic ImagingPet-mriPathologyPositron Emission TomographyOncology	2010	228
Brown fat in breast cancer patients: analysis of serial 18F-FDG PET/CT scans Caroline Rousseau, Emmanuelle Bourbouloux, L. Campion, European Journal of Nuclear Medicine and Molecular Imaging Medical ImagingBreast Cancer PatientsMedicineCancer DetectionBrown Fat	2006	90
Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography–computerised tomography in patients with non-small-cell lung cancer☆ Christian Périgaud, B. Bridji, J Roussel, European Journal of Cardio-Thoracic Surgery	2009	70
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma Éric Mirallié, Thomas Guillan, B. Bridji, Surgery Iodine-negative RecurrenceNeuro-oncologyRadiation TherapyMedicineIodine Deficiency Disorders	2007	69
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients Caroline Rousseau, Anne Devillers, Mario Campone, European Journal of Nuclear Medicine and Molecular Imaging Breast OncologyNeoadjuvant ChemotherapyStage IiOncologic ImagingMedicine	2011	59
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3) O. Palié, Pierre Michel, Jean-François Ménard, European Journal of Nuclear Medicine and Molecular Imaging Esophageal CancerRadiation TherapyGastrointestinal OncologyMedicineTreatment Response	2013	52
Interobserver Agreement of Qualitative Analysis and Tumor Delineation of <sup>18</sup>F-Fluoromisonidazole and 3′-Deoxy-3′-<sup>18</sup>F-Fluorothymidine PET Images in Lung Cancer S. Thureau, Philippe Chaumet‐Riffaud, Romain Modzelewski, Journal of Nuclear Medicine	2013	48
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma Amandine Pallardy, Caroline Bodet‐Milin, A. Oudoux, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyCervical CancerRecurrent Cervical CarcinomaMedicinePet-mri	2010	45

Page 1